Kinch MS - Search Results

1

Direct targeting of alphavbeta3 integrin on tumor cells with a monoclonal antibody, Abegrin.

Mulgrew K, Kinneer K, Yao XT, Ward BK, Damschroder MM, Walsh B, Mao SY, Gao C, Kiener PA, Coats S, Kinch MS, Tice DA. Mulgrew K, et al. Among authors: kinch ms. Mol Cancer Ther. 2006 Dec;5(12):3122-9. doi: 10.1158/1535-7163.MCT-06-0356. Mol Cancer Ther. 2006. PMID: 17172415

2

A human antibody-drug conjugate targeting EphA2 inhibits tumor growth in vivo.

Jackson D, Gooya J, Mao S, Kinneer K, Xu L, Camara M, Fazenbaker C, Fleming R, Swamynathan S, Meyer D, Senter PD, Gao C, Wu H, Kinch M, Coats S, Kiener PA, Tice DA. Jackson D, et al. Cancer Res. 2008 Nov 15;68(22):9367-74. doi: 10.1158/0008-5472.CAN-08-1933. Cancer Res. 2008. PMID: 19010911

3

Antibody-dependent cell-mediated cytotoxicity effector-enhanced EphA2 agonist monoclonal antibody demonstrates potent activity against human tumors.

Bruckheimer EM, Fazenbaker CA, Gallagher S, Mulgrew K, Fuhrmann S, Coffman KT, Walsh W, Ready S, Cook K, Damschroder M, Kinch M, Kiener PA, Woods R, Gao C, Dall'Acqua W, Wu H, Coats S. Bruckheimer EM, et al. Neoplasia. 2009 Jun;11(6):509-17, 2 p following 517. doi: 10.1593/neo.81578. Neoplasia. 2009. PMID: 19484140 Free PMC article.

4

Differential EphA2 epitope display on normal versus malignant cells.

Coffman KT, Hu M, Carles-Kinch K, Tice D, Donacki N, Munyon K, Kifle G, Woods R, Langermann S, Kiener PA, Kinch MS. Coffman KT, et al. Among authors: kinch ms. Cancer Res. 2003 Nov 15;63(22):7907-12. Cancer Res. 2003. PMID: 14633720

5

Selective targeting and potent control of tumor growth using an EphA2/CD3-Bispecific single-chain antibody construct.

Hammond SA, Lutterbuese R, Roff S, Lutterbuese P, Schlereth B, Bruckheimer E, Kinch MS, Coats S, Baeuerle PA, Kufer P, Kiener PA. Hammond SA, et al. Among authors: kinch ms. Cancer Res. 2007 Apr 15;67(8):3927-35. doi: 10.1158/0008-5472.CAN-06-2760. Cancer Res. 2007. PMID: 17440108

6

Tumor-selective response to antibody-mediated targeting of alphavbeta3 integrin in ovarian cancer.

Landen CN, Kim TJ, Lin YG, Merritt WM, Kamat AA, Han LY, Spannuth WA, Nick AM, Jennnings NB, Kinch MS, Tice D, Sood AK. Landen CN, et al. Among authors: kinch ms. Neoplasia. 2008 Nov;10(11):1259-67. doi: 10.1593/neo.08740. Neoplasia. 2008. PMID: 18953435 Free PMC article.

7

PC cell-derived growth factor expression in prostatic intraepithelial neoplasia and prostatic adenocarcinoma.

Pan CX, Kinch MS, Kiener PA, Langermann S, Serrero G, Sun L, Corvera J, Sweeney CJ, Li L, Zhang S, Baldridge LA, Jones TD, Koch MO, Ulbright TM, Eble JN, Cheng L. Pan CX, et al. Among authors: kinch ms. Clin Cancer Res. 2004 Feb 15;10(4):1333-7. doi: 10.1158/1078-0432.ccr-1123-03. Clin Cancer Res. 2004. PMID: 14977833

8

EphA2 expression is associated with aggressive features in ovarian carcinoma.

Thaker PH, Deavers M, Celestino J, Thornton A, Fletcher MS, Landen CN, Kinch MS, Kiener PA, Sood AK. Thaker PH, et al. Among authors: kinch ms. Clin Cancer Res. 2004 Aug 1;10(15):5145-50. doi: 10.1158/1078-0432.CCR-03-0589. Clin Cancer Res. 2004. PMID: 15297418

9

Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survival.

Kinch MS, Moore MB, Harpole DH Jr. Kinch MS, et al. Clin Cancer Res. 2003 Feb;9(2):613-8. Clin Cancer Res. 2003. PMID: 12576426

10

EphA2 overexpression decreases estrogen dependence and tamoxifen sensitivity.

Lu M, Miller KD, Gokmen-Polar Y, Jeng MH, Kinch MS. Lu M, et al. Among authors: kinch ms. Cancer Res. 2003 Jun 15;63(12):3425-9. Cancer Res. 2003. PMID: 12810680

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

124 results

Search Page

Filters